Intellectual Property
A1 Gene, Inc. is an established biopharma company focused on the discovery and development of advanced medical solutions. Its inventions are protected, maintaining a high standard of professionalism and integrity.
U.S. Patent Application, "Compositions For and Methods of Treatment With Mutant A1 Adenosine Receptor Plasmid cDNAs"
-U.S. Patent Application Number 19/734,574 Filed May 2, 2022
-U.S. Patent Application, CIP Number 19/302,246 Filed August 18, 2025
-PCT/US 23/66403 Filed April 28 2023